MCK
67
3
JBHT
65
2
AEP
61
-3
ECL
57
3
PCAR
52
-10
DD
45
-7
CAT
58
-8
URI
46
3
RSG
47
2
SCHW
64
6
CSCO
64
6
CMI
71
2
DTE
38
-4
GS
76
6
FDX
74
3
QCOM
45
2
REGN
59
2
GILD
56
6
GM
85
2
PSA
35
-11
MCK
67
3
JBHT
65
2
AEP
61
-3
ECL
57
3
PCAR
52
-10
DD
45
-7
CAT
58
-8
URI
46
3
RSG
47
2
SCHW
64
6
CSCO
64
6
CMI
71
2
DTE
38
-4
GS
76
6
FDX
74
3
QCOM
45
2
REGN
59
2
GILD
56
6
GM
85
2
PSA
35
-11
Financhill
Back

ProShares UltraShort Consumer Discretionary Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
9

SCC
ProShares UltraShort Consumer Discretionary

Last Price:
$13.90
Seasonality Move:
-3.14%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
9
ProShares UltraShort Consumer Discretionary (SCC) is a Sell

Is ProShares UltraShort Consumer Discretionary a Buy, Sell or Hold?

  • The current ProShares UltraShort Consumer Discretionary [SCC] share price is $13.94. The Score for SCC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SCC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCC Stock Price Chart

What is ProShares UltraShort Consumer Discretionary's stock price today?

  • The ProShares UltraShort Consumer Discretionary share price today is $13.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCC is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

SCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.63 Buy
Relative Strength Index (14 RSI): 39.81 Sell
Chaikin Money Flow: 16295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.1 - 15.8) Sell
Bollinger Bands (100): (14.29 - 16.05) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

SCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.11 Sell
20-day SMA: 14.64 Sell
50-day SMA: 14.87 Sell
200-day SMA: 17.79 Sell
8-day EMA: 7.41 Buy
20-day EMA: 3.63 Buy
50-day EMA: 1.58 Buy
200-day EMA: 0.41 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

ProShares UltraShort Consumer Discretionary Earnings Growth & SCC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

ProShares UltraShort Consumer Discretionary Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):